Medical Devices

Spectral Announces Normal Course Issuer Bid

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/15/14 -- Spectral Diagnostics Inc. ("Spectral" or the "Company") (TSX: SDI)(OTCQX: DIAGF) a Phase III company developing the first therano ...

Ventripoint Appoints Dr. Alan Rabinowitz to Board of Directors

SEATTLE, WASHINGTON: SEATTLE, WASHINGTON -- (Marketwired) -- 12/04/14 -- Ventripoint Diagnostics Ltd. ("Ventripoint") (TSX VENTURE: VPT) is pleased to announce the appointment of Dr. Alan Rabinowitz to the Boa ...

Medipure Holdings Appoints Doctor Rakshit Kodekalra as Director of Quality Assurance and Control

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/02/14 -- Medipure Holdings Inc. ("Medipure," or the "Company") (CSE: MDH) is pleased to announce that it has appointed Dr. Raks ...

SpectraScience Appoints Rand Mulford to the Board of Directors

SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 12/02/14 -- SpectraScience, Inc. (OTCQB: SCIE), a San Diego-based medical device company, today announced that its Board of Directors has appointed Rand Mulford to i ...

Largest Japanese Registry Data Analysis Demonstrates Significant Reduction in Mortality Rate of Septic Patients Treated With Toraymyxin(TM)

TORONTO, ONTARIO: - Data Presented at the American Society of Nephrology Supports Spectral's EUPHRATES Trial Design - Toraymyxin(TM) Treatment Resulted in an Approximate 25% Relative Reduction in Mortality ...

Venturi Ventures Issues 38,000 Options

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/20/14 -- Venturi Ventures Inc. (TSX VENTURE: VVV) (the "Company") announces that, pursuant to the Company's stock option plan, it ha ...

Event Cardio Group Acquires Worldwide Rights to Now Cardio(TM), Advanced Cardiac Monitoring Device

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 11/19/14 -- Event Cardio Group, Inc. (OTCQB: ECGI), a medical device company, announced it has finalized its acquisition of full intellectual property (IP) and develo ...

Bio-Rad Receives Premarket Application Approval for Its Geenius HIV 1/2 Supplemental Assay

HERCULES, CA: HERCULES, CA -- (Marketwired) -- 11/18/14 -- Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products life science researc ...

Cromos(TM) Pharma Launches Corium Research, a Premier Dermatology Site Research Organization

MOSCOW, RUSSIA: MOSCOW, RUSSIA -- (Marketwired) -- 11/18/14 -- Cromos™ Pharma, an international full-service CRO announced today that it launched Corium Research, a state of the art dermatology site research organ ...

Precision Optics Corporation, Inc. Announces Operating Results for the First Quarter of Fiscal Year 2015 Ended September 30, 2014

GARDNER, MA: GARDNER, MA -- (Marketwired) -- 11/13/14 -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") today announced operating results on an unaudited basis for its quarter ended Se ...